Quest Diagnostics (MEX:DGX) Dividends Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:DGX Quest Diagnostics Inc MEX:DGX
71 GF Score
Price MXN3,624.00
GF Value MXN3,288.23
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is Quest Diagnostics Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

MEX:DGX
71GF Score
Quest Diagnostics Inc MEX:DGX
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Quest Diagnostics (MEX:DGX) Overvalued in 2026?

Based on GuruFocus' analysis, Quest Diagnostics stock appears to be overvalued. The current stock price of MXN3,624.00 is trading 10.2% above its estimated GF Value™ of MXN3,288.23. GuruFocus considers Quest Diagnostics to be Fairly Valued.

Key valuation signals for MEX:DGX:

  • Dividends Received:
  • GF Value™: MXN3,288.23 vs. price of MXN3,624.00 (10.2% above fair value)
  • GF Score™: 71/100 with 8 warning signs

No single metric tells the full story. See the MEX:DGX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Quest Diagnostics Business Description

Address 500 Plaza Drive, Secaucus, NJ, USA, 07094
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 97% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,400 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.
71GF Score

Get the complete analysis for MEX:DGX

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN3,624.00
Price
MXN3,288.23
GF Value